1. Conget, P.A., Allers, C., and Minguell, J.J., Identification of a discrete population of human bone marrow-derived mesenchymal stem cells exhibiting properties of uncommitted progenitors, J. Hematother. Stem Cell Res., 2001, vol. 10, no. 6, pp. 749–758.
2. Domaratskaya, E.I., Starostin, V.I., and Pryanishnikova, O.D., Effect of 5-fluorouracil on clonogenic hematopoietic cells (CFU-C) of embryos and adult mice, Izv. Akad. Nauk, Ser. Biol., 1995, no. 4, pp. 398–402.
3. Dominici, M., Le Blanc, K., Mueller, I., et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement, Cytotherapy, 2006, vol. 8, no. 4, pp. 315–317.
4. Friedenstein, A.J., Gorskaya, J.F., and Kulagina, N.N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs, Exp. Hematol., 1976, vol. 4, no. 5, pp. 267–274.
5. Ivanović, Z., Bartolozzi, B., Bernabei, P.A., et al., A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors, Stem Cells, 1999, vol. 17, no. 4, pp. 219–225.